Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients.

Future Microbiol · 2022 · PMC8826831 · PMID 35135310

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

IVM used alone has been tested in more than 20 randomized, controlled trials (RCTs) for COVID-19 treatment, with statistically highly significant clinical benefits in almost all of these and an average of 62% reduction in risk of death [ 5 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.